GynecologyGynecology2079-56962079-5831Consilium Medicum3347810.26442/20795696.2019.4.190563UnknownLate reproductive age and modern technology---15082019214273216042020Copyright © 2019, Consilium Medicum2019[Инструкция по медицинскому применению лекарственного препарата Дюфастон® 10 мг, таблетки покрытые пленочной оболочкой, 26.02.2018.][Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C. Use of oral dydrogesterone for luteal phase support in fresh IVF cycles is associated with an increase in live birth rate: an integrated individual patient data analysis of the lotus phase iii trial program. Fertil Steril 2018;110(4):e90.][Pandian R.U. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 2009; 65 Suppl 1: S47-S50.][Kumar A. et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial Fertility and Sterility 2014;5; 0015-0282.][Coomarasamy A. et al. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy. New England Journal of Medicine, 2019; 380:1815-1824. DOI: 10.1056/NEJMoa1813730.][Coomarasamy A. et al. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med. 2015 Nov 26;373(22):2141-8][Тетруашвили Н.К., Агаджанова А.А. Дидрогестерон в лечении угрожающего и привычного выкидыша // Медицинский совет, 2018, №13. - С. 34-38.][Прохоренко Н.Ф. Демографический потенциал: дополнительные аспекты // ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2019. Т. 5, № 2. С.22-47.]